A5J-28874-31014
5 vaccinations
9 coded responses
29 check-ins
9 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 750 / TX
- Registered
- 2021-03-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
3B8-10947-13103
Child or adolescent in my care · Male · 2021-11-09
LZ3-32815-87605
Child or adolescent in my care · Female · 2022-06-24
Timeline
-
2021-03-01
Dose 1 — Pfizer-BioNTech
-
2021-03-02
Registered in v-safe
-
2021-03-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-03-02
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-03
Survey response — days 1–6 daily, dose 1MedDRA: Anaphylaxis treatment — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Anaphylaxis reaction 10 minutes after receiving initial vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-03-06
- 2021-03-07
- 2021-03-08
-
2021-03-15
Survey response — day 14, dose 1MedDRA: Diarrhoea, Nausea, Vomiting — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Vomiting, diarrhea, nauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-23
Dose 2 — Pfizer-BioNTech
-
2021-03-24
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Survey response — days 1–6 daily, dose 2MedDRA: Insomnia — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Trouble sleepingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-27
Survey response — days 1–6 daily, dose 2MedDRA: Insomnia — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessFree text: Trouble sleeping since after receiving shotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-31
- 2021-04-08
- 2021-04-20
- 2021-05-02
- 2021-05-06
-
2021-09-01
Dose 3 — Pfizer-BioNTech
-
2021-09-21
Survey response — 6 months, dose 2MedDRA: Asthma, Atelectasis, Bronchopulmonary aspergillosis allergic, Hospitalisation — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Hospitalized for uncontrolled asthma, Allergic bronchopulmonary aspergillosis, Atelectasis.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-21
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-09-22
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-10-02
- 2021-10-06
- 2021-10-13
-
2022-03-03
Survey response — 6 months, dose 3MedDRA: Asthma, Hospitalisation, Pre-existing disease, Tachycardia, Viral infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, HospitalizationFree text: Viral illness leading to hospitalization (5 days) for asthma exacerbation and persistent tachycardia.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-03
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-03-04
Call successfulParticipant prefers to complete VAERS report online
-
2022-04-20
Dose 4 — Pfizer-BioNTech
- 2022-09-03
-
2022-09-17
Dose 5 — Pfizer-BioNTech
-
2022-09-18
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain, Redness, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2022-09-19
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-09-20
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-23
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-24
Health check-in — day 7, dose 5Feeling: Fair · Site: Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-02
Survey response — day 14, dose 5MedDRA: Asthma, Oxygen saturation decreased — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Frequent asthma attacks with regular episodes of low ox satMedDRA releases: 2024-11 · check-in free text available
-
2022-10-08
Survey response — day 21, dose 5MedDRA: Asthma, Fatigue, Oxygen saturation decreased — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: More frequent and prolonged drops in ox sat. Frequent asthma attacks. Profound exhaustion.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-08
Report sent to call center — day 21, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-10-10
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Pfizer-BioNTech | |
| 2 | 2021-03-23 | Pfizer-BioNTech | |
| 3 | 2021-09-01 | Pfizer-BioNTech | No |
| 4 | 2022-04-20 | Pfizer-BioNTech | No |
| 5 | 2022-09-17 | Pfizer-BioNTech | No |
Call center
5 call center cases
5 successful
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Anaphylaxis reaction 10 minutes after receiving initial vaccine.
Release 5 — day 14, dose 1
Symptoms: Vomiting, diarrhea, nausea
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Shortness of breath
Systemic reaction (other): Trouble sleeping
Systemic reaction (other): Trouble sleeping since after receiving shot
Release 9 — 6 months, dose 2
Symptoms: Hospitalized for uncontrolled asthma, Allergic bronchopulmonary aspergillosis, Atelectasis.
Release 11 — 6 months, dose 3
Symptoms: Viral illness leading to hospitalization (5 days) for asthma exacerbation and persistent tachycardia.
Release 12 — day 14, dose 5
Symptoms: Frequent asthma attacks with regular episodes of low ox sat
Release 12 — day 21, dose 5
Symptoms: More frequent and prolonged drops in ox sat. Frequent asthma attacks. Profound exhaustion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Atelectasis | · | · | ✓ |
| SD | Bronchopulmonary aspergillosis allergic | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Oxygen saturation decreased | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
| SRO | Anaphylaxis treatment | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release